HIV News and Research

RSS

New startup launched to overcome the challenge of delivering next-generation therapeutics

Harvard University's Office of Technology Development (OTD) and the Harvard T.H. Chan School of Public Health today announced the launch of Vesigen Therapeutics, a startup company that aims to overcome the challenge of delivering next-generation therapeutics, such as gene-editing complexes, RNA molecules, and other large proteins, to intracellular targets in specific tissues of interest.

23 Jul 2020

New pathways that could help treat RNA viruses discovered

Researchers at the University of New Hampshire have identified new pathways in an RNA-based virus where inhibitors, like medical treatments, unbind.

23 Jul 2020

Researchers comprehensively describe the 'human tissue virome atlas'

Human-resident microbes can influence both health and disease. Investigating the microbiome using next-generation sequencing technology has revealed examples of mutualism and conflict between microbes and humans.

22 Jul 2020

New tools developed to test the ability of antibodies to neutralize SARS-CoV-2

Researchers at The Rockefeller University in New York have developed new tools to rapidly test the ability of antibodies to neutralize SARS-CoV-2, the novel coronavirus responsible for the COVID-19 pandemic.

22 Jul 2020

New method reveals the dynamics of HIV Gag-protein lattice structure

Viruses are scary. They invade our cells like invisible armies, and each type brings its own strategy of attack. While viruses devastate communities of humans and animals, scientists scramble to fight back.

17 Jul 2020

Study: LGBT-friendly medical practices can improve HIV and STD screening rates

This report--describing the first national quality improvement collaborative focused on providing culturally affirming care for LGBT people--finds that making primary care practices more LGBT-friendly and inclusive may improve STD and HIV screening rates among this vulnerable population.

15 Jul 2020

The immune system can play a key role in improving recovery from heart attacks

International research collaboration to pioneer the field of immuno-cardiology and investigate ways to harness the power of the immune system to improve recovery from heart attacks will be led at the Perelman School of Medicine at the University of Pennsylvania by Jonathan Epstein, MD, executive vice dean, chief scientific officer and the William Wikoff Smith Professor of Cardiovascular Research.

14 Jul 2020

NIH establishes clinical trial network to test vaccines and monoclonal antibodies for COVID-19

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has established a new clinical trial network that aims to enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19.

14 Jul 2020

Modeling research shows increase in HIV, TB, and malaria deaths due to COVID-19 pandemic

But there is still an opportunity to substantially reduce the death toll by prioritizing the most critical services, specifically antiretroviral therapy for HIV, timely TB diagnosis and treatment, and provision of long-lasting insecticide-treated nets for malaria, researchers say.

14 Jul 2020

Study shows promise for developing novel COVID-19 therapeutics

A protein known as polymerase is used by SARS-CoV-2—the coronavirus that is responsible for causing the worldwide COVID-19 pandemic—to replicate its genome within the infected human cells.

1 Jul 2020

Lab-grown 'mini-brains' can be infected by SARS-CoV-2 virus

A multidisciplinary team from two Johns Hopkins University institutions, including neurotoxicologists and virologists from the Bloomberg School of Public Health and infectious disease specialists from the school of medicine, has found that organoids (tiny tissue cultures made from human cells that simulate whole organs) known as "mini-brains" can be infected by the SARS-CoV-2 virus that causes COVID-19.

1 Jul 2020

Sanford Burnham Prebys announces research agreement with Lilly to characterize COVID-19 antibodies

Sanford Burnham Prebys Medical Discovery Institute today announced a research agreement with Eli Lilly and Company (Lilly) to characterize Lilly's next-generation anti-SARS-CoV-2 antibodies.

30 Jun 2020

Chemist Develops Potential Drug To Treat Type 2 Diabetes Without Harsh Side Effects

Professor Dr. Robert P. Doyle has developed a new drug to treat type 2 diabetes in millions of patients who are seeking to better control their blood sugar.

24 Jun 2020

Detecting antibodies in minutes using glowing proteins, thread and a smartphone camera

To defend the body, the immune system makes proteins known as antibodies that latch onto the perceived threat, be it HIV, the new coronavirus or, as is the case in autoimmune disease, part of the body itself.

22 Jun 2020

Study shows how viruses evade antiviral defenses

According to a new study, researchers have identified a novel antiviral defense system that can possibly be used for treating several viral infections.

17 Jun 2020

Study sheds light on the complexity of HIV-1 nuclear entry

The process of cells being infected by HIV-1 strains is widely known to undergo many stages.

2 Jun 2020

EKF secures COVID-19 novel sample collection kit manufacturing and supply contracts

EKF Diagnostics, the global in vitro diagnostics company, announces it has secured new contracts for the manufacture and supply of a novel, patented sample collection device which allows COVID-19 samples to be rapidly inactivated in the collection tube, avoiding contamination and preserving RNA without need for refrigeration.

From EKF Diagnostics 26 May 2020

Study shows how plant viral protein disrupts cell division to promote its own propagation

Viruses are ever-present pathogens that lead to severe infectious diseases in humans as well as in agricultural crops.

14 May 2020

New antimicrobial peptide proves more effective in fighting drug-resistant bacteria

Through serendipity, researchers at the University of Pittsburgh Graduate School of Public Health considerably reduced the toxicity of a potential antibiotic against the most feared drug-resistant bacteria, while also improving its stability in fighting infections.

4 May 2020

Research on rare molecule aims to improve treatments for cancer, HIV

Stanford University chemist Paul Wender and his colleagues are working to improve treatments for cancer, HIV and Alzheimer's - and they are betting that a drab, weedy marine invertebrate is the means to achieving that end.

28 Apr 2020

HIV News and Research

New startup launched to overcome the challenge of delivering next-generation therapeutics

New pathways that could help treat RNA viruses discovered

Researchers comprehensively describe the 'human tissue virome atlas'

New tools developed to test the ability of antibodies to neutralize SARS-CoV-2

New method reveals the dynamics of HIV Gag-protein lattice structure

Study: LGBT-friendly medical practices can improve HIV and STD screening rates

The immune system can play a key role in improving recovery from heart attacks

NIH establishes clinical trial network to test vaccines and monoclonal antibodies for COVID-19

Modeling research shows increase in HIV, TB, and malaria deaths due to COVID-19 pandemic

Study shows promise for developing novel COVID-19 therapeutics

Lab-grown 'mini-brains' can be infected by SARS-CoV-2 virus

Sanford Burnham Prebys announces research agreement with Lilly to characterize COVID-19 antibodies

Chemist Develops Potential Drug To Treat Type 2 Diabetes Without Harsh Side Effects

Detecting antibodies in minutes using glowing proteins, thread and a smartphone camera

Study shows how viruses evade antiviral defenses

Study sheds light on the complexity of HIV-1 nuclear entry

EKF secures COVID-19 novel sample collection kit manufacturing and supply contracts

Study shows how plant viral protein disrupts cell division to promote its own propagation

New antimicrobial peptide proves more effective in fighting drug-resistant bacteria

Research on rare molecule aims to improve treatments for cancer, HIV

Quorum Bio: Where Synthetic Biology Meets Sustainable Farming

Diagnostic Biochips: Pioneering Brain Research Tools for the Future

Commercializing Innovation in a Life Sciences Ecosystem

Latest in Genomics